Cybersecurity in healthcare is about more than protecting data — it’s about protecting patients. The attack surface has never been broader as medical devices become increasingly connected to hospital networks, cloud platforms, and even patients’ homes. Weak security in a medical device doesn’t just expose data; it can delay treatment, disrupt diagnoses, or even cause direct patient harm.
To address these risks, cybersecurity must be built into medical devices from the start — not bolted on later. Below is an authoritative guide to best practices that manufacturers should follow to align with FDA expectations, international standards, and patient safety needs.
1. Security by Design, Not as an Afterthought
Cybersecurity must be part of the Secure Product Development Framework (SPDF). This means integrating threat modeling, risk assessment, and security requirements into device architecture early. By considering cybersecurity alongside safety and functionality, vulnerabilities can be reduced before products reach the market.
Threat Modeling in Practice
Manufacturers can apply frameworks like STRIDE (Spoofing, Tampering, Repudiation, Information Disclosure, Denial of Service, Elevation of Privilege) or attack trees to identify how devices could be targeted. For example, an insulin pump may be vulnerable to unauthorized wireless access, which could result in dosage manipulation. Documenting these risks early ensures they are addressed before clinical deployment.
2. Authentication and Access Controls
Devices should only be accessible to authorized users, software, and systems. Role-based access control for clinicians and administrators, multi-factor authentication where feasible, and strong credential management are all necessary to reduce the risk of compromise. FDA recalls have shown that weak or hard-coded credentials are a recurring problem, making it critical to address this issue early.
3. Encryption and Secure Communication
Patient data — whether stored on the device or transmitted wirelessly — must be encrypted. Secure communication protocols such as TLS or DTLS protect integrity and confidentiality. Without these measures, devices remain exposed to interception and tampering. A 2019 FDA advisory warned about vulnerabilities in certain cardiac implants that lacked strong encryption, leaving patient data and device commands at risk. Encryption is now an essential expectation.
4. Regular Updates and Patch Management
Cyber threats evolve faster than device lifecycles. Manufacturers must design devices to support secure software and firmware updates. This includes digital signing of update packages, secure delivery mechanisms, and verification processes to prevent tampering. Without patching, devices become liabilities. Past advisories for insulin pumps and implantable devices highlight the importance of building update mechanisms into device design.
5. Monitoring, Logging, and Intrusion Detection
Devices should log security events and integrate with hospital security operations centers. Logs must be tamper-resistant and provide forensic value in the event of an incident. At the network level, anomaly detection helps identify suspicious behavior across connected fleets of devices. Healthcare organizations increasingly deploy network-based intrusion detection systems that monitor device behavior. Devices that provide visibility and structured logging reduce time to detection and response.
6. Testing and Validation
Cybersecurity is not complete without rigorous validation. Manufacturers should conduct penetration testing against real-world attack scenarios, perform static and dynamic code analysis to identify flaws, and use vulnerability scanning tied to an SBOM (Software Bill of Materials) to track risks in third-party components. FDA has emphasized that SBOMs are essential for transparency and postmarket vulnerability management. Without them, organizations cannot assess exposure to emerging threats like Log4j or OpenSSL flaws.
7. Supplier and Third-Party Risk Management
Most medical devices rely on third-party components, from operating systems to cloud platforms. Each dependency introduces potential vulnerabilities. Manufacturers must vet suppliers for security maturity, require SBOMs from vendors, and conduct risk assessments of third-party libraries and services. The URGENT/11 and SweynTooth vulnerabilities demonstrated how flaws in common third-party components can cascade across entire categories of devices.
8. Labeling and User Instructions
FDA guidance stresses the importance of clear labeling that provides configuration instructions for secure deployment, update and patching procedures, and contact information for reporting vulnerabilities. This ensures healthcare providers can maintain device security throughout its lifecycle.
9. Lifecycle Security and Postmarket Management
Cybersecurity doesn’t end at FDA clearance. Continuous monitoring, coordinated vulnerability disclosure programs, and postmarket support plans are essential. FDA expects manufacturers to manage security across the Total Product Lifecycle, including patch development and deployment, ongoing threat monitoring, and transparency with customers and regulators.
10. Aligning with Standards and Regulations
While FDA guidance provides U.S.-specific direction, manufacturers should align with global standards such as ISO 27001 for information security management, ISO 14971 for risk management with a focus on patient safety, IEC 81001-5-1 for health software safety, and the NIST Cybersecurity Framework for overall maturity. These frameworks help create a harmonized approach that meets both domestic and international regulatory expectations.
Final Thoughts
Cybersecurity in medical device design is not optional; it’s a patient safety requirement. Manufacturers who embed cybersecurity into their SPDF meet FDA and international expectations and build trust with providers and patients.
At Blue Goat Cyber, we help device makers implement these best practices through threat modeling, penetration testing, SBOM analysis, and compliance support — ensuring devices are secure by design, compliant by necessity, and safe for patients.